Tourmaline Bio, Inc. (TRML)
Oct 28, 2025 - TRML was delisted (reason: acquired by NVS)
47.98
0.00 (0.00%)
Inactive · Last trade price on Oct 27, 2025
Tourmaline Bio Employees
Tourmaline Bio had 74 employees as of December 31, 2024. The number of employees increased by 30 or 68.18% compared to the previous year.
Employees
74
Change (1Y)
30
Growth (1Y)
68.18%
Revenue / Employee
n/a
Profits / Employee
-$1,195,595
Market Cap
1.24B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 74 | 30 | 68.18% |
| Dec 31, 2023 | 44 | - | - |
TRML News
- 6 days ago - Novartis completes acquisition of Tourmaline Bio - GlobeNewsWire
- 6 days ago - Novartis announces expiration of Tourmaline Bio tender offer - GlobeNewsWire
- 12 days ago - Novartis announces expiration of Hart-Scott-Rodino waiting period of Tourmaline Bio tender offer - GlobeNewsWire
- 27 days ago - Tourmaline Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML - Business Wire
- 5 weeks ago - Novartis announces commencement of tender offer to acquire Tourmaline Bio - GlobeNewsWire
- 7 weeks ago - TOURMALINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML - Business Wire
- 7 weeks ago - This Small Biotech Stock Is Surging Today. Here's Why. - Investopedia
- 7 weeks ago - Tourmaline Bio surges after Novartis $1.4 billion acquisition; analysts see strong fit - Invezz